Structure of cardiac rhythm disorders in patients with obesity and associated with it dyslipidemia as an arrhythmogenic factor

Obesity is a global public health problem in the twenty-first century. The most adverse it’s effects are associated with visceral type, with accumulation of epicardial fat, showing high metabolic activity, dysfunction and important role in the development of lipotoxic cardiomyopathy linked with significant morphological and functional myocardial changes, accompanying by high risk of heart rhythm disorders. The aim of the study: to identify structure (frequency and character) of cardiac arrhythmias in men of employable age with visceral obesity, to establish the relationship of arrhythmias with features of the blood lipid spectrum of these patients. Material and methods. 98 men with abdominal obesity and 46 overweight patients were examined. The control group consisted of 40 healthy patients with normal body weight. All the patients were undergone ECG monitoring, echocardiography and analysis of serum lipid levels. Results. The presence of obesity is statistically significantly associated with the risk of supraventricular couplets, frequent ventricular extrasystoles, sinus arrhythmia and atrial fibrillation. The increase in the severity of obesity was accompanied by a tendency to a greater frequency of arrhythmias: in obesity of I degree, the frequency of atrial fibrillation was 12.3%, II–III degree — 21.2%, p = 0.25; frequent ventricular extrasystoles with similar degrees of obesity — 13.8% and 21.1%, respectively. Atrial fibrillation was significantly more often detected against the background of lipid disorders, mainly with a decrease in HDLP. Conclusion. The main type of heart rhythm disturbance in patients with obesity are supraventricular arrhythmias, mainly atrial fibrillation, the frequency of which increases in proportion to the increase in the patient's body weight. Abdominal obesity leads to an increase in ventricular ectopic activity. Dyslipidemia is the one of risk factors for arrhythmias in these patients.

1. Obesity and inequities. Guidance for addressing inequities in overweight and obesity (2014). [Electronic resource]. URL: http://www.euro.who.int/en/publications/abstracts/obesity-and-inequities.-guidance-for-addressing-inequities-in-overweight-and-obesity-2014. Accessed 29.01.2019.

2. Shelton R.C., Pencina M.J., Barrentine L.W., Ruiz J.A., Fava M Zajecka J.M. et al. Association of obesity and inflammatory marker levels on treatment outcome: results from a double-blind, randomized study of adjunctive Lmethylfolate calcium in patients with MDD who are inadequate responders to SSRIs. J. Clin. Psychiatry. 2015;76(12):1635–41. DOI: 10.4088/JCP.14m09587

3. Lavie C.J., De Schutter A., Parto P., Jahangir E., Kokkinos P., Ortega F.B. et al. Obesity and prevalence of cardiovascular diseases and prognosis: the obesity paradox updated. Prog. Cardiovasc. Dis. 2016;58(5):537–47. DOI: 10.1016/j.pcad.2016.01.008

4. Long M.T., Fox C.S. The Framingham Heart Study-67 years of discovery in metabolic disease. Nat. Rev. Endocrinol. 2016;12(3):177–83. DOI: 10.1038/nrendo.2015.226

5. Vecchié A., Dallegri F., Carbone F., Bonaventura A., Liberale L., Portincasa P. Obesity phenotypes and their paradoxical association with cardiovascular diseases. Eur. J. Intern. Med. 2018;48:6–17. DOI: 10.1016/j.ejim.2017.10.020

6. Phillips C.M. Metabolically healthy obesity across the life course: epidemiology, determinants, and implications. Ann. NY Acad. Sci. 2017;1391(1):85–100. DOI: 10.1111/nyas.13230

7. Smith U. Abdominal obesity: a marker of ectopic fat accumulation. J. Clin. Invest. 2015;125(5):1790–2. DOI: 10.1172/JCI81507

8. Hatem S.N., Redheuil A., Grandjbakhch Е. Cardiac adipose tissue and atrial fibrillation. Cardiovasc. Res. 2016;109(4):502–9. DOI:10.1093/cvr/cvw001

9. Kosmala W., Sanders P., Marwick T.H. Subclinical myocardial impairment in metabolic diseases. JACC Cardiovasc. Imaging. 2017;10(6):692–703. DOI: 10.1016/j.jcmg.2017.04.001

10. Wu C.K., Tsai H.Y., Su M.M., Wu Y.F., Hwang J.J., Lin J.L. et al. Evolutional change in epicardial fat and its correlation with myocardial diffuse fibrosis in heart failure patients. J. Clin. Lipidol. 2017;11(6):1421–1431. DOI: 10.1016/j.jacl.2017.08.018

11. Al-Rawahi M., Proletti R., Thansoulis G. Pericardial fat and atrial fibrillation: epidemiology, mechanisms and interventions. Int. J. Cardiol. 2015;195:98–103. DOI: 10.1016/j.ijcard.2015.05.129

12. Drosatos K., Bharadwaj K., Lymperopoulos A., Ikeda S., Khan R., Hu Y. et al. Cardiomyocyte lipids impair beta-adrenergic receptor function via pkc activation. Am. J. Physiol. Endocrinol. Metab. 2011;300:489–499. DOI: 10.1152/ajpendo.00569.2010

13. Drosatos K., Schulze P. Cardiac lipotoxicity: molecular pathways and therapeutic implications. Curr. Heart Fail. Rep. 2013;10(2):109–121. DOI: 10.1007/s11897-013-0133-0

14. Alpert M.A., Karthikeyan K., Abdullah O., Ghadban R. Obesity and cardiac remodeling in adults: mechanisms and clinical implications. Prog. Cardiovasc. Dis. 2018;61(2):114–123. DOI: 10.1016/j.pcad.2018.07.012

15. Lavie C.J., Pandey A., Lau D.H., Alpert M.A., Sanders P. Obesity and atrial fibrillation prevalence, pathogenesis, and prognosis: effects of weight loss and exercise. J. Am. Coll. Cardiol. 2017;70(16):2022–2035. DOI: 10.1016/j.jacc.2017.09.002

16. Alpert M.A., Omran J., Mehra A., Ardhanari S. Impact of obesity and weight loss on cardiac performance and morphology in adults. Prog. Cardiovasc. Dis. 2014;56(4):391–400. DOI: 10.1016/j.pcad.2013.09.003

17. Alpert M.A., Omran J., Bostick B.P. Effects of obesity on cardiovascular hemodynamics, cardiac morphology, and ventricular function. Curr. Obes. Rep. 2016;5(4):424–434. DOI: 10.1007/s13679-016-0235-6

18. Pathak R.K., Mahajan R., Lau D.H., Sanders P. The implications of obesity for cardiac arrhythmia mechanisms and management. Can. J. Cardiol. 2015;31(2):203–10. DOI: 10.1016/j.cjca.2014.10.027

19. Mozos I. Arrhythmia risk and obesity. J. Molecular and Genetic Medicine. 2014;s1(01). DOI: 10.4172/1747-0862.s1-006

20. Sandhu R., Conen D., Tedrow U., Fitzerald K., Pradham A., Ridker M. et al. Predisposing factors associated with development of persistent compared with paroxysmal atrial fibrillation. J. Am. Heart Assoc. 2014;3:e000916. DOI: 10.1161/JAHA.114.000916

21. Lin Y., Chen Y., Chen S. Potential atrial arrhythmogenicity of adipocytes: Implications for the genesis of atrial fibrillation. Med. Hypotheses. 2010;74(6):1026–9.

22. Nalliah C., Sanders P., Kottkamp H., Kalman J. The role of obesity in atrial fibrillation. European Heart Journal. 2016;37(20):1565–72. DOI: 10.1093/eurheartj/ehv486

23. Pathak R.K., Middeldorp M.E., Meredith M., Mehta A.B., Mahajan R., Wong C.X. et al. Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY). J. Am. Coll. Cardiol. 2015;65(20):2159–69. DOI: 10.1016/j.jacc.2015.03.002

24. Huang H., Gurin A., Wan E., Thorp E., Homma S., Morrow J. et al. Diet-induced obesity causes long QT and reduces transcription of voltage-gated potassium channels. J. Mol. Cell Cardiol. 2013;59:151–58. DOI: 10.1016/j.yjmcc.2013.03.007

25. Mahajan R., Lau D.H., Brooks A.G., Shipp N.J., Manavis J., Wood J. et al. Electrophysiological, electroanatomical, and structural remodeling of the atria as consequences of sustained obesity. J. Am. Coll. Cardiol. 2015;66(1):1–11. DOI: 10.1016/j.jacc.2015.04.058

26. Lau D.H., Nattel S., Kalman J.M., Sanders P. Modifiable risk factors and atrial fibrillation. Circulation. 2017;136(6):583–596. DOI: 10.1161/CIRCULATIONAHA.116.023163

27. Baek Y., Yang P., Kim T., Uhm J., Park J., Pak H. et al. Associations of abdominal obesity and new-onset atrial fibrillation in the general population. J. Am. Heart Assoc. 2017;6(6):e004705. DOI: 10.1161/JAHA.116.004705

28. Sabbag A., Sidi Y., Kivity S., Beinart R., Glikson M., Segev S. et al. Obesity and exercise-induced ectopic ventricular arrhythmias in apparently healthy middle aged adults. Eur. J. Prev. Cardiol. 2016;23(5):511–7. DOI: 10.1177/2047487315591442

29. Plourde B., Sarrazin J.F., Nault I., Poirier P. Sudden cardiac death and obesity. Expert Rev. Cardiovasc. Ther. 2014;12(9):1099–110. DOI: 10.1586/14779072.2014.952283

30. Narayanan K., Zhang L., Kim C., Uy-Evanado A., Teodorescu C., Reinier K. et al. QRS fragmentation and sudden cardiac death in the obese and overweight. J. Am. Heart Assoc. 2015;4(3):e001654. DOI: 10.1161/JAHA.114.001654

31. Karam B., Chavez-Moreno A., Koh W., Akar J.G., Akar F.G. Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes. Cardiovasc Diabetol. 2017;16(1):120. DOI: 10.1186/s12933-017-0604-9

32. Goudis C.A., Korantzopoulos P., Ntalas I.V., Kallergis E.M., Ketikoglou D.G. Obesity and atrial fibrillation: A comprehensive review of the pathophysiological mechanisms and links. J. Cardiol. 2015;66(5):361–9. DOI: 10.1016/j.jjcc.2015.04.002

33. Björnson E., Adiels M., Taskinen M.R., Borén J. Kinetics of plasma triglycerides in abdominal obesity. Curr. Opin. Lipidol. 2017;28(1):11–18. DOI: 10.1097/MOL.0000000000000375

34. Franco L.P., Morais C.C., Cominetti C. Normal-weight obesity syndrome: diagnosis, prevalence, and clinical implications. Nutr. Rev. 2016;74(9):558–70. DOI: 10.1093/nutrit/nuw019

35. Du X., Dong J., Ma C. Is Atrial fibrillation a preventable disease? J. Am. Coll. Cardiol. 2017;69(15):1968–1982. DOI: 10.1016/j.jacc.2017.02.020

36. Aydin M., Susam I., Kilicaslan B., Dereli M., Sacar M., Ozdogan O. Serum cholesterol levels and postoperative atrial fibrillation. J. Cardiothorac. Surg. 2014;9:69. DOI: 10.1186/1749-8090-9-69

37. Gizurarson S., Stahlman M., Omerovic E., Jeppsson A. Atrial fibrillation in patients admitted to coronary care unit in western Sweden – focus on obesity and lipotoxicity. J. Electrocardiol. 2015;48(5):853–60. DOI: 10.1016/j.jelectrocard.2014.12.010

38. Khawaja O., Bartz T., Ix J.H., Heckbert S., Kizer J., Zieman S. et al. Plasma free fatty acids and risk of atrial fibrillation (from the Cardiovascular Health Study). Am. J. Cardiol. 2012;110(2):212–6. DOI: 10.1016/j.amjcard.2012.03.010

39. Lau D., Schotten U., Mahajan R., Antic N., Hatem S., Pathak R. et al. Novel mechanisms in the pathogenesis of atrial fibrillation: practical applications. European Heart J. 2016;37:1573–1581. DOI:10.1093/eurheartj/ehv375